FDA Adverse Event Injury Summary report: N

SMR SHOULDER

MDR report key: 25200752 · Received May 18, 2026

Report

Report Number
3008021110-2026-00208
Event Type
Injury
Date Received
May 18, 2026
Date of Event
March 18, 2026
Report Date
May 18, 2026
Manufacturer
LIMACORPORATE S.P.A
Product Code
PHX
UDI-DI
08033390102940
PMA / PMN Number
K142139
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 0

PRELIMINARY REVIEW OF MANUFACTURING RECORDS DID NOT IDENTIFY ANY PRE-EXISTING NON-CONFORMITY THAT COULD HAVE CONTRIBUTED TO REPORTED ISSUE. THE MANUFACTURER WILL SUBMIT A FINAL REPORT AS SOON AS THE INVESTIGATION IS COMPLETED.

Description of Event or Problem · 0

REVISION SURGERY WAS PERFORMED ON (B)(6) 2026 DUE TO SHOULDER DISLOCATION. PREVIOUS SURGERY OCCURRED ON (B)(6) 2023 FOR A REVERSE TOTAL SHOULDER ARTHROPLASTY, WITH FOLLOWING COMPONENTS: - SMR TT BASEPLATE SMALL-R (PN 1375.15.605), - SMR GLENOID PEG TT SMALL-R #MEDIUM (PN 1375.14.652), - CONNECTOR LAR +2MM SMALL-R (PN 1374.15.312), - GLENOSPHERE DIA40MM (PN 1374.09.121, LOT 2213444, STERILIZATION (B)(4)), - FINNED STEM SHORT DIA25MM (PN 1304.15.025), - 140° REVERSE HUMERAL BODY (PN 1352.15.011). - REVERSE LINER +6MM DIA40MM (PN 1365.50.820, LOT 22AT0WC, STERILIZATION (B)(4)). AROUND 3 YEARS AFTER PREVIOUS SURGERY, PATIENT DISLOCATED. PRE-EXISTING CONNECTOR, GLENOSPHERE, REVERSE HUMERAL BODY AND LINER WERE REMOVED AND REPLACED WITH A MORE LATERALIZED AND THICK ASSEMBLY CONSISTING OF: - CONNECTOR LAT +4MM (PN 1374.15.314), - GLENOSPHERE ECCENTRICAL DIA 40MM (PN 1376.09.041), - 140° REVERSE HUMERAL BODY (PN 1352.15.011), - EXTENSION FOR HUMERAL REVERSE BODY (PN 1352.15.001), - REVERSE LINER +6MM DIA40MM (PN 1365.50.820). SURGERY WAS COMPLETED AS INTENDED. PATIENT IS MALE, DATE OF BIRTH (B)(6) 1953. THE EVENT OCCURRED IN THE UNITED STATES.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
384055 SMR SHOULDER REVERSE LINER 40MM +6MM PHX LIMACORPORATE S.P.A 1365.50.820 22AT0WC 08033390102940

Patients

Seq Age Sex Outcome Treatment
1